Helen Piwnica-Worms

Biology & Biomedical Sciences (Molecular Cell Biology) Washington University, Saint Louis, St. Louis, MO 
Molecular Biology, Cell Biology
"Helen Piwnica-Worms"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hollander Pd, Shah S, Zhou X, et al. (2019) Abstract 4669: Overcoming therapy resistance in stem cell-rich triple negative breast cancer through p38 MAP kinase inhibition Cancer Research. 79: 4669-4669
Werden SJ, Sphyris N, Sarkar TR, et al. (2016) Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth. Oncogene
Teasley DC, Parajuli S, Nguyen M, et al. (2015) Flap Endonuclease 1 Limits Telomere Fragility on the Leading Strand. The Journal of Biological Chemistry. 290: 15133-45
Chen X, Kim IK, Honaker Y, et al. (2015) 14-3-3 proteins restrain the Exo1 nuclease to prevent overresection. The Journal of Biological Chemistry. 290: 12300-12
Diamond MI, Cai S, Boudreau A, et al. (2015) Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1. The Journal of Biological Chemistry. 290: 9075-86
Valliani AA, Sen T, Masrorpour F, et al. (2015) Abstract 5316: Check point kinase 1 (Chk1) targeting as a novel therapeutic strategy in small cell lung cancer (SCLC) Cancer Research. 75: 5316-5316
Huh J, Piwnica-Worms H. (2013) CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Molecular and Cellular Biology. 33: 213-26
Duxin JP, Moore HR, Sidorova J, et al. (2012) Okazaki fragment processing-independent role for human Dna2 enzyme during DNA replication. The Journal of Biological Chemistry. 287: 21980-91
Lee G, Origanti S, White LS, et al. (2011) Contributions made by CDC25 phosphatases to proliferation of intestinal epithelial stem and progenitor cells. Plos One. 6: e15561
Lennerz JK, Hurov JB, White LS, et al. (2010) Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis. Molecular and Cellular Biology. 30: 5043-56
See more...